These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 25987622

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
    Jeong BH, Jeon K, Park HY, Kim SY, Lee KS, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.
    Am J Respir Crit Care Med; 2015 Jan 01; 191(1):96-103. PubMed ID: 25393520
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol.
    Nakagawa T, Hashimoto H, Yagi M, Kogure Y, Sekimizu M, Saito AM, Ogawa K, Inoue Y.
    BMJ Open Respir Res; 2019 Jan 01; 6(1):e000434. PubMed ID: 31258920
    [Abstract] [Full Text] [Related]

  • 6. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
    Lam PK, Griffith DE, Aksamit TR, Ruoss SJ, Garay SM, Daley CL, Catanzaro A.
    Am J Respir Crit Care Med; 2006 Jun 01; 173(11):1283-9. PubMed ID: 16514112
    [Abstract] [Full Text] [Related]

  • 7. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
    Griffith DE, Brown BA, Cegielski P, Murphy DT, Wallace RJ.
    Clin Infect Dis; 2000 Feb 01; 30(2):288-92. PubMed ID: 10671330
    [Abstract] [Full Text] [Related]

  • 8. Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease.
    Moon SM, Yoo IY, Huh HJ, Lee NY, Jhun BW.
    Antimicrob Agents Chemother; 2019 Dec 20; 64(1):. PubMed ID: 31611366
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.
    Hasegawa N, Nishimura T, Ohtani S, Takeshita K, Fukunaga K, Tasaka S, Urano T, Ishii K, Miyairi M, Ishizaka A.
    Chest; 2009 Dec 20; 136(6):1569-1575. PubMed ID: 19542259
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis.
    Wallace RJ, Zhang Y, Brown-Elliott BA, Yakrus MA, Wilson RW, Mann L, Couch L, Girard WM, Griffith DE.
    J Infect Dis; 2002 Jul 15; 186(2):266-73. PubMed ID: 12134265
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
    Koh WJ, Jeong BH, Jeon K, Lee SY, Shin SJ.
    Am J Respir Crit Care Med; 2012 Oct 15; 186(8):797-802. PubMed ID: 22878282
    [Abstract] [Full Text] [Related]

  • 13. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    Adachi Y, Tsuyuguchi K, Kobayashi T, Kurahara Y, Yoshida S, Kagawa T, Hayashi S, Suzuki K.
    J Infect Chemother; 2020 Jul 15; 26(7):676-680. PubMed ID: 32171660
    [Abstract] [Full Text] [Related]

  • 14. Semiquantitative Culture Analysis during Therapy for Mycobacterium avium Complex Lung Disease.
    Griffith DE, Adjemian J, Brown-Elliott BA, Philley JV, Prevots DR, Gaston C, Olivier KN, Wallace RJ.
    Am J Respir Crit Care Med; 2015 Sep 15; 192(6):754-60. PubMed ID: 26068042
    [Abstract] [Full Text] [Related]

  • 15. Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease.
    Jeong BH, Jeon K, Park HY, Moon SM, Kim SY, Lee SY, Shin SJ, Daley CL, Koh WJ.
    Antimicrob Agents Chemother; 2016 Oct 15; 60(10):6076-83. PubMed ID: 27480854
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of intermittent maintenance therapy after successful treatment of Mycobacterium avium complex lung disease.
    Asakura T, Nakagawa T, Suzuki S, Namkoong H, Morimoto K, Ishii M, Kurashima A, Betsuyaku T, Ogawa K, Hasegawa N, Nontuberculous Mycobacteriosis Japan Research Consortium (NTM-JRC).
    J Infect Chemother; 2019 Mar 15; 25(3):218-221. PubMed ID: 30172726
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S, Shirai M, Toyoshima M, Shirai T, Yasuda K, Yokomura K, Yamada T, Masuda M, Inui N, Chida K, Suda T, Hayakawa H.
    Ann Am Thorac Soc; 2014 Jan 15; 11(1):23-9. PubMed ID: 24298907
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of Mycobacterium avium Complex (MAC).
    Griffith DE.
    Semin Respir Crit Care Med; 2018 Jun 15; 39(3):351-361. PubMed ID: 30071550
    [Abstract] [Full Text] [Related]

  • 20. Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.
    Ramirez J, Mason C, Ali J, Lopez FA.
    J La State Med Soc; 2008 Jun 15; 160(5):248-54; quiz 254, 293. PubMed ID: 19048978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.